Simplex Trading’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Simplex Trading’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-6,500	Closed	-$65K	–	10276
2023 Q4	$65K	Buy	+6,500	New	+$29.5K	﹤0.01%	5838

Simplex Trading's GRCL Position: Q1 2024 in Review

Simplex Trading sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 1,622 shares — an estimated $16K sold.

Simplex Trading first reported a position in GRCL in Q4 2023 and held it in 1 quarter. The position peaked at $16K in Q4 2023. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

Simplex Trading reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Simplex Trading sold 1,622 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $16K.
Simplex Trading first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q4 2023 and held it in 1 quarter.
Simplex Trading's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $16K in Q4 2023.
0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.